Log in with your email address username.


Attention doctorportal newsletter subscribers,

After December 2018, we will be moving elements from the doctorportal newsletter to MJA InSight newsletter and rebranding it to Insight+. If you’d like to continue to receive a newsletter covering the latest on research and perspectives in the medical industry, please subscribe to the Insight+ newsletter here.

As of January 2019, we will no longer be sending out the doctorportal email newsletter. The final issue of this newsletter will be distributed on 13 December 2018. Articles from this issue will be available to view online until 31 December 2018.

[Comment] Engaging men in HIV treatment and prevention

Much has been accomplished over the past two decades in global HIV treatment and prevention. Although in need of renewed emphasis, the worldwide scale-up of antiretroviral therapy (ART) has gone beyond what many imagined possible. Oral pre-exposure prophylaxis (PrEP) is available in many high-income countries and in some lower-income and middle-income countries. The US President’s Emergency Plan for AIDS Relief (PEPFAR) and other funders are expanding access to rapid or same-day ART initiation and piloting PrEP programmes in international settings.